Social Technology · public health · autonomy · supply

Drugs: Evidence,
Experience & Supply.

A collection for difficult questions without moral shortcuts

Drugs can be prescribed, purchased, prohibited, helpful, harmful, meaningful, dependence-forming or contaminated. A legal category does not settle pharmacology, and one experience does not settle population risk.

This space asks readers to compare sources, understand uncertainty and investigate before making claims or decisions.

Reader note

This collection is for public discussion, not medical or legal advice and not an instruction to take an illegal drug. It does not recommend stopping prescribed medicine suddenly. Some medicines can cause dangerous withdrawal; urgent concerns require a pharmacist, prescriber, NHS 111 or emergency care as appropriate.

How this collection reads information

Four kinds of knowledge.
None disguised as another.

01

Established evidence

Research, official guidance, law, laboratory results and documented public records—with source and date visible.

02

Reported experience

What a person or frontline worker noticed. A possible signal and source of questions, not population proof by itself.

03

Interpretation or proposal

The author’s reasoning about what the combined material may mean or what society could test differently.

04

Open question

Something not yet established: a gap requiring better records, investigation, comparison or a measured pilot.

Published and in preparation

The papers

P—51Policy paper · 28 September 2026Published with 29 September supplement

Cannabis · NHS access · safe supply · illustrative public finance

A Call for Legalisation of Cannabis Through the NHS

A 22-page policy paper proposes four standardised reference products, tested supply, clinical recording and a measured public-health pilot. A separate 13-page supplement contains the full evidence matrix, financial scenarios and proposed NHS registry specification. The scenarios are illustrative, not forecasts.

Read the paper and supplement →
P—36Discussion draft · 11 September 2026Published

Bodily autonomy · informed consent · harm reduction · accountable medicine

Drug Knowledge, Body Autonomy and Patient Choice

From punishment to care: a rights-based but risk-aware discussion paper bringing scientific evidence, lived experience, product testing, professional observation and individual values into the same examinable frame.

Read the publication frame →
Next paperFentanyl · UK supply pathwaysIn preparation

Investigation announced · findings not yet published

How fentanyl is making its way to UK streets

The forthcoming paper will examine supply pathways, product substitution and contamination, official alerts, toxicology, frontline observations and lived reports. Until the research is complete, this card makes no claim about prevalence, route or cause.

Publication rule: distinguish verified detections from warnings, individual reports from population patterns, and plausible pathways from demonstrated supply chains.

Related studyNHS Right to ChooseOpen question

Working research specification · findings not yet published

What happens to NHS Right to Choose funding after referral?

This study in formation asks how NHS-funded private-provider payments relate to completed care, treatment, prescribing continuity and sustained outcomes. It does not assume that financial loss or wrongdoing has occurred.

Read the question and study plan →

The collection’s question

Can we replace fear and certainty with knowledge, consent and accountable care?

Research first. Read across perspectives. Protect the freedom to question—and the duty to name real risk.